Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

VolumeIssuePage

Issues

Cell Therapy and Transplantation in Parkinsons Disease

Olle Lindvall / Peter Hagell

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 39, Issue 4, Pages 356–361, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2001.056, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Transplanted human fetal dopamine neurons can reinnervate the striatum in patients with Parkinson's disease (PD). Recent findings using positron emission tomography indicate that the grafts are functionally integrated and restore dopamine release in the patient's striatum. The grafts can exhibit long-term survival without immunological rejection and despite an ongoing disease process and continuous antiparkinsonian drug treatment. In the most successful cases, patients have been able to withdraw L-dopa treatment after transplantation and resume an independent life. About two-thirds of grafted patients have shown clinically useful, partial recovery of motor function. The major obstacle for the further development of this cell replacement strategy is that large amounts of human fetal mesencephalic tissue are needed for therapeutic effects. Stem cells hold promise as a virtually unlimited source of self-renewing progenitors for transplantation. The possibility to generate dopamine neurons from such cells is now being explored using different approaches. However, so far the generated neurons have survived poorly after transplantation in animals.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Daniel J. Costello, Gerard W. O'Keeffe, Fiona M. Hurley, and Aideen M. Sullivan
Journal of Cellular and Molecular Medicine, 2012, Volume 16, Number 10, Page 2451
[2]
Xiaowei Li, Eleni Katsanevakis, Xiaoyan Liu, Ning Zhang, and Xuejun Wen
Progress in Polymer Science, 2012, Volume 37, Number 8, Page 1105
[3]
M. Brodhun, R. Bauer, and S. Patt
Experimental and Toxicologic Pathology, 2004, Volume 56, Number 1-2, Page 103
[4]
E.M. Torres, C. Monville, P.R. Lowenstein, M.G. Castro, and S.B. Dunnett
Brain Research Bulletin, 2005, Volume 68, Number 1-2, Page 31
[6]
J.D. Newcomb, M. Janowski, T. Zigova, S. Saporta, M.P. McGrogan, P.R. Sanberg, and A.E. Willing
Life Sciences, 2007, Volume 81, Number 6, Page 441
[7]
Birgitta H. Quittenbaum and Birgitta Grahn
Parkinsonism & Related Disorders, 2004, Volume 10, Number 3, Page 129
[8]
E.M. Torres, C. Monville, M.A. Gates, V. Bagga, and S.B. Dunnett
Neuroscience, 2007, Volume 146, Number 4, Page 1606
[9]
J.D. Elsworth, D.E. Redmond, C. Leranth, K.B. Bjugstad, J.R. Sladek, T.J. Collier, S.B. Foti, R.J. Samulski, K.P. Vives, and R.H. Roth
Experimental Neurology, 2008, Volume 211, Number 1, Page 252
[10]
Young-Tae Kim, Robert Hitchcock, Kelly W. Broadhead, Darin J. Messina, and Patrick A. Tresco
Journal of Controlled Release, 2005, Volume 102, Number 1, Page 101
[11]
Cesario V Borlongan and Paul R Sanberg
Drug Discovery Today, 2002, Volume 7, Number 12, Page 674
[12]
Dag Nyholm and Sten-Magnus Aquilonius
Clinical Neuropharmacology, 2004, Volume 27, Number 5, Page 245
[13]
Neha Singh, Viness Pillay, and Yahya E. Choonara
Progress in Neurobiology, 2007, Volume 81, Number 1, Page 29
[14]
Simone M. Smits, J. Peter H. Burbach, and Marten P. Smidt
Progress in Neurobiology, 2006, Volume 78, Number 1, Page 1
[15]
D. Chichung Lie, Hongjun Song, Sophia A. Colamarino, Guo-li Ming, and Fred H. Gage
Annual Review of Pharmacology and Toxicology, 2004, Volume 44, Number 1, Page 399
[16]
Joanna A Korecka, Joost Verhaagen, and Elly M Hol
Regenerative Medicine, 2007, Volume 2, Number 4, Page 425
[17]
J. Schwarz
Der Nervenarzt, 2010, Volume 81, Number 10, Page 1160
[18]
C. Apel, O. V. Forlenza, V. J. R. de Paula, L. L. Talib, B. Denecke, C. P. Eduardo, and W. F. Gattaz
Journal of Neural Transmission, 2009, Volume 116, Number 1, Page 71
[19]
Ana Sofia Correia, Sergey V. Anisimov, Jia‐Yi Li, and Patrik Brundin
Annals of Medicine, 2005, Volume 37, Number 7, Page 487
[20]
M. A. Aleksandrova, O. V. Podgornyi, M. V. Marei, R. A. Poltavtseva, E. B. Tsitrin, D. V. Gulyaev, L. V. Cherkasova, A. V. Revishchin, L. I. Korochkin, N. G. Khrushchov, and G. N. Sukhikh
Bulletin of Experimental Biology and Medicine, 2005, Volume 139, Number 1, Page 114
[21]
Chris Ganchoff
Sociology of Health and Illness, 2004, Volume 26, Number 6, Page 757
[22]
Toshie Kanayasu-Toyoda, Teruhide Yamaguchi, Tadashi Oshizawa, and Takao Hayakawa
Journal of Cellular Physiology, 2003, Volume 195, Number 1, Page 119

Comments (0)

Please log in or register to comment.